These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22282462)

  • 1. Acquisition of carbapenem resistance in multiresistant Klebsiella pneumoniae strains harbouring blaCTX-M-15, qnrS1 and aac(6')-Ib-cr genes.
    Ruiz E; Ocampo-Sosa AA; Rezusta A; Revillo MJ; Román E; Torres C; Martínez-Martínez L
    J Med Microbiol; 2012 May; 61(Pt 5):672-677. PubMed ID: 22282462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of association of OmpK35 and OmpK36 alteration and bla
    Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
    Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outbreak caused by a multi-resistant Klebsiella pneumoniae strain of new sequence type ST341 carrying new genetic environments of aac(6')-Ib-cr and qnrS1 genes in a neonatal intensive care unit in Spain.
    Ruiz E; Rojo-Bezares B; Sáenz Y; Olarte I; Esteban I; Rocha-Gracia R; Zarazaga M; Torres C
    Int J Med Microbiol; 2010 Nov; 300(7):464-9. PubMed ID: 20547103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae.
    García-Sureda L; Doménech-Sánchez A; Barbier M; Juan C; Gascó J; Albertí S
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4742-7. PubMed ID: 21807980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Klebsiella pneumoniae LamB Porin in antimicrobial resistance.
    García-Sureda L; Juan C; Doménech-Sánchez A; Albertí S
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1803-5. PubMed ID: 21282437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
    Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae.
    Vera-Leiva A; Carrasco-Anabalón S; Lima CA; Villagra N; Domínguez M; Bello-Toledo H; González-Rocha G
    J Glob Antimicrob Resist; 2018 Mar; 12():73-76. PubMed ID: 29275225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.
    Kaczmarek FM; Dib-Hajj F; Shang W; Gootz TD
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3396-406. PubMed ID: 17005822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
    Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM
    J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of blaOXA-48 and aac(6')-Ib-cr genes in Klebsiella pneumoniae isolates from Istanbul, Turkey.
    Nazik H; Öngen B; Mete B; Aydin S; Yemişen M; Keleşoğlu FM; Ergul Y; Tabak F
    J Int Med Res; 2011; 39(5):1932-40. PubMed ID: 22117996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.
    Webster DP; Gaulton T; Woodford N; Pike R; Turton J; Perry C; Bowler IC
    Int J Antimicrob Agents; 2010 Dec; 36(6):575-6. PubMed ID: 20869852
    [No Abstract]   [Full Text] [Related]  

  • 12. Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production.
    Shi W; Li K; Ji Y; Jiang Q; Wang Y; Shi M; Mi Z
    Braz J Microbiol; 2013; 44(2):435-42. PubMed ID: 24294234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from Thailand.
    Lunha K; Chanawong A; Lulitanond A; Wilailuckana C; Charoensri N; Wonglakorn L; Saenjamla P; Chaimanee P; Angkititrakul S; Chetchotisakd P
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):221-6. PubMed ID: 27041106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates.
    Kim SY; Park YJ; Yu JK; Kim HS; Park YS; Yoon JB; Yoo JY; Lee K
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):85-91. PubMed ID: 16854555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development.
    Mena A; Plasencia V; García L; Hidalgo O; Ayestarán JI; Alberti S; Borrell N; Pérez JL; Oliver A
    J Clin Microbiol; 2006 Aug; 44(8):2831-7. PubMed ID: 16891499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-drug carbapenem-resistant Klebsiella pneumoniae infection carrying the OXA-48 gene and showing variations in outer membrane protein 36 causing an outbreak in a tertiary care hospital in Riyadh, Saudi Arabia.
    Uz Zaman T; Aldrees M; Al Johani SM; Alrodayyan M; Aldughashem FA; Balkhy HH
    Int J Infect Dis; 2014 Nov; 28():186-92. PubMed ID: 25245001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy.
    Findlay J; Hamouda A; Dancer SJ; Amyes SG
    Clin Microbiol Infect; 2012 Feb; 18(2):140-6. PubMed ID: 21745255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
    Sho T; Muratani T; Hamasuna R; Yakushiji H; Fujimoto N; Matsumoto T
    Microb Drug Resist; 2013 Aug; 19(4):274-81. PubMed ID: 23514607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
    Joshi P; Shrivastava R; Bhagwat S; Patel M
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115481. PubMed ID: 34332307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo selection of carbapenem-resistant Klebsiella pneumoniae by OmpK36 loss during meropenem treatment.
    Song W; Suh B; Choi JY; Jeong SH; Jeon EH; Lee YK; Hong SG; Lee K
    Diagn Microbiol Infect Dis; 2009 Dec; 65(4):447-9. PubMed ID: 19766430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.